These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 38411836)

  • 1. MYCN immunohistochemistry as surrogate marker for MYCN-amplified spinal ependymomas.
    Mohan D; Nambirajan A; Malik R; Sharma A; Suri V; Kaur K; Doddamani R; Garg A; Gupta S; Mallick S; Sharma MC
    Hum Cell; 2024 May; 37(3):704-713. PubMed ID: 38411836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinically aggressive pediatric spinal ependymoma with novel MYC amplification demonstrates molecular and histopathologic similarity to newly described MYCN-amplified spinal ependymomas.
    Shatara M; Schieffer KM; Klawinski D; Thomas DL; Pierson CR; Sribnick EA; Jones J; Rodriguez DP; Deeg C; Hamelberg E; LaHaye S; Miller KE; Fitch J; Kelly B; Leraas K; Pfau R; White P; Magrini V; Wilson RK; Mardis ER; Abdelbaki MS; Finlay JL; Boué DR; Cottrell CE; Ghasemi DR; Pajtler KW; Osorio DS
    Acta Neuropathol Commun; 2021 Dec; 9(1):192. PubMed ID: 34895332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spinal Cord Ependymomas With MYCN Amplification Show Aggressive Clinical Behavior.
    Swanson AA; Raghunathan A; Jenkins RB; Messing-Jünger M; Pietsch T; Clarke MJ; Kaufmann TJ; Giannini C
    J Neuropathol Exp Neurol; 2019 Sep; 78(9):791-797. PubMed ID: 31373367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High level MYCN amplification and distinct methylation signature define an aggressive subtype of spinal cord ependymoma.
    Raffeld M; Abdullaev Z; Pack SD; Xi L; Nagaraj S; Briceno N; Vera E; Pittaluga S; Lopes Abath Neto O; Quezado M; Aldape K; Armstrong TS; Gilbert MR
    Acta Neuropathol Commun; 2020 Jul; 8(1):101. PubMed ID: 32641156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ependymomas of the spinal region in adults: Clinical and pathological features and MYCN expression levels in spinal ependymomas and myxopapillary ependymomas.
    Topel G; Dirilenoğlu F; Sevin İE; Kahraman A
    Ann Diagn Pathol; 2024 Jun; 70():152299. PubMed ID: 38555652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MYCN amplification in spinal ependymoma: A five-year retrospective study.
    Rao S; Sugur H; Konar S; Arivazhagan A; Santosh V
    Neuropathology; 2023 Dec; 43(6):457-462. PubMed ID: 37221449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MYCN amplification drives an aggressive form of spinal ependymoma.
    Ghasemi DR; Sill M; Okonechnikov K; Korshunov A; Yip S; Schutz PW; Scheie D; Kruse A; Harter PN; Kastelan M; Wagner M; Hartmann C; Benzel J; Maass KK; Khasraw M; Sträter R; Thomas C; Paulus W; Kratz CP; Witt H; Kawauchi D; Herold-Mende C; Sahm F; Brandner S; Kool M; Jones DTW; von Deimling A; Pfister SM; Reuss DE; Pajtler KW
    Acta Neuropathol; 2019 Dec; 138(6):1075-1089. PubMed ID: 31414211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pediatric spinal ependymoma with chromothripsis of chromosome 6: a case report and review of the literature.
    Scott KR; Gener MA; Repnikova EA
    J Med Case Rep; 2024 Feb; 18(1):95. PubMed ID: 38351155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential involvement of protein 4.1 family members DAL-1 and NF2 in intracranial and intraspinal ependymomas.
    Singh PK; Gutmann DH; Fuller CE; Newsham IF; Perry A
    Mod Pathol; 2002 May; 15(5):526-31. PubMed ID: 12011257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular genetic alterations on chromosomes 11 and 22 in ependymomas.
    Lamszus K; Lachenmayer L; Heinemann U; Kluwe L; Finckh U; Höppner W; Stavrou D; Fillbrandt R; Westphal M
    Int J Cancer; 2001 Mar; 91(6):803-8. PubMed ID: 11275983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgical outcomes in spinal cord ependymomas and the importance of extent of resection in children and young adults.
    Safaee M; Oh MC; Mummaneni PV; Weinstein PR; Ames CP; Chou D; Berger MS; Parsa AT; Gupta N
    J Neurosurg Pediatr; 2014 Apr; 13(4):393-9. PubMed ID: 24506340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The response of spinal cord ependymomas to bevacizumab in patients with neurofibromatosis Type 2.
    J Neurosurg Spine; 2017 Apr; 26(4):474-482. PubMed ID: 27982762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spinal cord ependymomas and myxopapillary ependymomas in the first 2 decades of life: a clinicopathological and immunohistochemical characterization of 19 cases.
    Stephen JH; Sievert AJ; Madsen PJ; Judkins AR; Resnick AC; Storm PB; Rushing EJ; Santi M
    J Neurosurg Pediatr; 2012 Jun; 9(6):646-53. PubMed ID: 22656257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostics of pediatric supratentorial RELA ependymomas: integration of information from histopathology, genetics, DNA methylation and imaging.
    Pagès M; Pajtler KW; Puget S; Castel D; Boddaert N; Tauziède-Espariat A; Picot S; Debily MA; Kool M; Capper D; Sainte-Rose C; Chrétien F; Pfister SM; Pietsch T; Grill J; Varlet P; Andreiuolo F
    Brain Pathol; 2019 May; 29(3):325-335. PubMed ID: 30325077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations of protein 4.1 family members in ependymomas: a study of 84 cases.
    Rajaram V; Gutmann DH; Prasad SK; Mansur DB; Perry A
    Mod Pathol; 2005 Jul; 18(7):991-7. PubMed ID: 15731777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidermal growth factor receptor overexpression is common and not correlated to gene copy number in ependymoma.
    Friedrich C; von Bueren AO; Kolevatova L; Bernreuther C; Grob T; Sepulveda-Falla D; van den Boom L; Westphal M; Simon R; Glatzel M
    Childs Nerv Syst; 2016 Feb; 32(2):281-90. PubMed ID: 26686534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular genetic analysis of ependymal tumors. NF2 mutations and chromosome 22q loss occur preferentially in intramedullary spinal ependymomas.
    Ebert C; von Haken M; Meyer-Puttlitz B; Wiestler OD; Reifenberger G; Pietsch T; von Deimling A
    Am J Pathol; 1999 Aug; 155(2):627-32. PubMed ID: 10433955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spinal cord ependymomas in children and adolescents.
    Benesch M; Frappaz D; Massimino M
    Childs Nerv Syst; 2012 Dec; 28(12):2017-28. PubMed ID: 22961356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morphology-based molecular classification of spinal cord ependymomas using deep neural networks.
    Schumann Y; Dottermusch M; Schweizer L; Krech M; Lempertz T; Schüller U; Neumann P; Neumann JE
    Brain Pathol; 2024 Sep; 34(5):e13239. PubMed ID: 38205683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation Between
    Santiago T; Tarek N; Boulos F; Hayes C; Jeha S; Raimondi S; Rodriguez-Galindo C
    J Glob Oncol; 2019 Jul; 5():1-7. PubMed ID: 31365300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.